✦ LIBER ✦

Electroconvulsive therapy and cyclophosphamide in combination for severe neuropsychiatric lupus with catatonia

✍ Scribed by Gregory L. Fricchione; Lee D. Kaufman; Barry L. Gruber; Max Fink

Book ID: 115683246
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 266 KB
Volume: 88
Category: Article
ISSN: 1555-7162
DOI: 10.1016/0002-9343(90)90509-c

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Electroconvulsive Therapy for Catatonia

Electroconvulsive Therapy for Catatonia in a Boy With Hydrocephalus and an Arachnoid Cyst

✍ Lee E. Wachtel; Kristin Baranano; Irving M. Reti 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Induction therapy with low-dose intraven

Induction therapy with low-dose intravenous cyclophosphamide, oral mizoribine, and steroids for severe lupus nephritis in children

✍ Shuichiro Fujinaga; Kazunari Kaneko; Yoshiyuki Ohtomo; Hitohiko Murakami; Masaru 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 322 KB

Dramatic efficacy of cyclophosphamide pu

Dramatic efficacy of cyclophosphamide pulsed therapy combined with double–filtration plasmapheresis for treating severe massive pulmonary hemorrhage associated with systemic lupus erythematosus

✍ T. Ito; K. Inose; S. Horie; Y. Okubo; R. Yoshida; K. Nakazawa; K. Nakada 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 412 KB

Risk factors for ovarian failure in pati

Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy

✍ Chi Chiu Mok; Chak Sing Lau; Raymond Woon Sing Wong 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 772 KB

## Objective: To determine the incidence of ovarian failure after cyclophosphamide (cyc) treatment for systemic lupus erythematosus (sle) and to identify the risk factors for this complication. ## Methods: The records of 70 premenopausal female sle patients treated with cyc were reviewed retrospe

Use of a gonadotropin-releasing hormone

Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus

✍ Emily C. Somers; Wendy Marder; Gregory M. Christman; Vladimir Ognenovski; W. Jos 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

## Abstract ## Objective Cyclophosphamide (CYC) therapy for systemic lupus erythematosus (SLE), a disease predominantly affecting women of childbearing age, causes an unacceptably high incidence of irreversible premature ovarian failure (POF). This study was performed to evaluate the effectiveness

Combination therapy with rFVIIa and plat

Combination therapy with rFVIIa and platelets for hemorrhage in patients with severe thrombocytopenia and alloimmunization

✍ Bipin N. Savani; Cynthia E. Dunbar; Margaret E. Rick 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB 👁 2 views